The indispensable role of professional judgment in genomic medicine

JAMA

Volumn 309, Issue 14, 2013, Pages 1465-1466

  McGuire, Amy L ^a   McCullough, Laurence B ^a   Evans, James P ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; DECISION MAKING; GENETIC PROCEDURES; GENETIC VARIABILITY; GENOMICS; HUMAN; MEDICAL CARE; MEDICAL RESEARCH; PATIENT AUTONOMY; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL JUDGMENT; PROFESSIONAL KNOWLEDGE; SHORT SURVEY; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING;

EID: 84875912503     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.1438     Document Type: Short Survey

References (5)

1. Knoppers BM, Joly Y, Simard J, Durocher F. The emergence of an ethical duty to disclose genetic research results: international perspectives. Eur J Hum Genet. 2006;14(11):1170-1178.
2. Beauchamp TL, Faden RR. A History and Theory of Informed Consent. New York, NY: Oxford University Press; 1986.
3. Brierley KL, Blouch E, Cogswell W, et al. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer J . 2012;18(4):303-309.
4. Plon SE, Eccles DM, Easton D, et al; IARC Unclassified Genetic Variants Working Group. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29(11):1282-1291.
5. Langreth R. Fumbled DNA Tests Mean Peril for Breast-Cancer Patients. Bloomberg News. http://www.bloomberg.com/news/2012-09-10/fumbled-dna-tests-mean- peril-for-breast-cancer-patients.html. Published September 10, 2012. Accessed January 18, 2013.